Sanofi (SNY) Equity Income (2009 - 2026)
Sanofi's Equity Income was -$10.46 million in the quarter ended Jun 30, 2026, compared with $48.67 million a year earlier.
Sanofi (SNY) Equity Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sanofi's Equity Income was -$177.59 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was $327.65 million, up 269.2% from the prior year.
- Equity Income shows a five-year compound annual growth rate of -4.2% (years ended Dec 2020 to Dec 2025).
- In earlier years, Equity Income was $88.75 million in the year ended Dec 31, 2024 (-72.0%), $316.94 million in the year ended Dec 31, 2023 (+241.7%), $92.75 million in the year ended Dec 31, 2022 (+101.0%) and $46.15 million in the year ended Dec 31, 2021 (-88.6%).
- Quarterly Equity Income has moved between -$277.04 million (the quarter ended Dec 31, 2025) and $200.36 million (the quarter ended Jun 30, 2023) over five years.
- Compared with a year earlier, Equity Income was higher in two of the last four quarters, with an average decline of 26.0%.
- The best year-over-year quarter for Equity Income over five years was the quarter ended Sep 30, 2023 (growth of 902.5%); the worst was the quarter ended Dec 31, 2021 (a decline of 89.6%).
- Per Business Quant data, SNY's Equity Income in the three quarters before the quarter ended Jun 30, 2026 was $12.88 million (quarter ended Mar 31, 2026), -$277.04 million (quarter ended Dec 31, 2025) and $97.03 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | - |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Sanofi | 50.73 Bn | 17.66 Bn | 10.79 Bn | -10.46 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.46 Mn |
| Mar 31, 2026 | 12.88 Mn |
| Dec 31, 2025 | -180.43 Mn |
| Sep 30, 2025 | 97.03 Mn |
| Jun 30, 2025 | 48.67 Mn |
| Mar 31, 2025 | 44.18 Mn |
| Dec 31, 2024 | -5.34 Mn |
| Sep 30, 2024 | 80.17 Mn |
| Jun 30, 2024 | 22.61 Mn |
| Mar 31, 2024 | -46.71 Mn |
| Dec 31, 2023 | -146.33 Mn |
| Sep 30, 2023 | 70.76 Mn |
| Jun 30, 2023 | -69.69 Mn |
| Mar 31, 2023 | 12.88 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 7.06 Mn |
| Jun 30, 2022 | 29.88 Mn |
| Mar 31, 2022 | 33.67 Mn |
| Dec 31, 2021 | 20.59 Mn |
| Sep 30, 2021 | -5.90 Mn |
Sanofi Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=SNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();